Point72 Asset Management

Point72 Asset Management’s Stemline Therapeutics, Inc. STML Stock Holding History

Point72 Asset Management’s Portfolio STML Stock Details STML Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell
2019 Q3	$2.26M	Sell
2019 Q2	$7.95M	Buy
2019 Q1	$2.25M	Sell
2018 Q4	$2.85M	Buy
2018 Q3	$4.32M	Buy
2018 Q2	$3.45M	Sell
2018 Q1	$3.83M	Buy